par8o
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
par8o - overview
Established
2011
Location
Cambridge, MA, US
Primary Industry
Healthcare IT
About
par8o is a healthcare technology company focused on enhancing patient engagement and streamlining care coordination through innovative solutions that integrate into healthcare systems. Founded in 2011 in Cambridge, US, par8o specializes in healthcare solutions aimed at optimizing patient care. The company has completed a total of 4 deals, with its most recent funding round being a VENTURE DEBT of USD 3. 00 mn on December 15, 2021, led by United Group, bringing the total amount raised to USD 10.
50 mn. The CEO and founder, Daniel Palestrant, has a background in healthcare innovation. par8o offers innovative healthcare solutions that enhance patient engagement and streamline care coordination through a technology platform. This platform improves communication between providers, patients, and payers, addressing critical needs such as optimizing care pathways, managing chronic diseases, and ensuring timely access to medical services.
The company primarily serves healthcare providers, payers, and patients in the United States, focusing on improving operational efficiencies and patient outcomes. The revenue model of par8o is based on a subscription service tailored for healthcare organizations and providers. Clients access the platform on a recurring basis, benefiting from a comprehensive suite of services for effective patient management and care coordination. The company partners with healthcare systems and practitioners to deliver services directly to end-users, with pricing plans designed to accommodate various organizational sizes and needs, contributing significantly to its revenue stream.
Looking ahead, par8o aims to expand its product offerings and geographic reach. The company plans to develop new healthcare solutions, although specific release dates have not been disclosed. Recent funding will be allocated to support these initiatives. Following its acquisition by Cloudmed in December 2021, which aims to enhance Cloudmed's 340B Discovery solution and elevate the CloudmedAI technology platform, par8o is positioned to deliver more value across the revenue cycle and implement cost savings through digitally verifiable compliance trails.
Current Investors
Cloudmed, LLC, IMA Consulting, Atlas Venture
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT
Website
www.par8o.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.